Inncardio Announces Acquisition of Cengent Therapeutics

Inncardio, a company founded by Bioaccelerate Holdings, announced today a definitive agreement to acquire Cengent Therapeutics Inc., a privately held, structure-guided drug discovery company based in San Diego, CA. Inncardio is a biotechnology company focused on the development of treatments and therapies targeted at cardiovascular-related diseases.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-01-2005/0003297775&EDATE=)